SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer

BACKGROUND: Endocrine resistance in estrogen receptor-positive (ER+) breast cancer is a major clinical problem and is associated with accelerated cancer cell growth, increased motility and acquisition of mesenchymal characteristics. However, the specific molecules and pathways involved in these alte...

Descripción completa

Detalles Bibliográficos
Autores principales: Alves, Carla L., Elias, Daniel, Lyng, Maria B., Bak, Martin, Ditzel, Henrik J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009053/
https://www.ncbi.nlm.nih.gov/pubmed/29921289
http://dx.doi.org/10.1186/s13058-018-0988-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009053/
https://www.ncbi.nlm.nih.gov/pubmed/29921289
http://dx.doi.org/10.1186/s13058-018-0988-9

Ejemplares similares